FIM
PACB icon

Freedom Investment Management’s Pacific Biosciences PACB Stock Holding History

Freedom Investment Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-29,166
Closed -$36.2K – 513
2025
Q2 		$36.2K Buy
29,166
+4,560
+19% +$5.27K ﹤0.01% 725
2025
Q1 		$29K Sell
24,606
-24,185
-50% -$37.1K ﹤0.01% 732
2024
Q4 		$89.3K Sell
48,791
-326
-0.7% -$636 0.01% 736
2024
Q3 		$83.5K Sell
49,117
-11,022
-18% -$18.1K 0.01% 742
2024
Q2 		$82.4K Buy
60,139
+44,700
+290% +$90.3K 0.01% 749
2024
Q1 		$57.9K Buy
15,439
+4,947
+47% +$29K ﹤0.01% 772
2023
Q4 		$103K Sell
10,492
-1,085
-9% -$8.87K 0.01% 727
2023
Q3 		$96.7K Sell
11,577
-2,519
-18% -$28.8K 0.01% 650
2023
Q2 		$187K Buy
14,096
+2,304
+20% +$28K 0.02% 657
2023
Q1 		$137K Sell
11,792
-709
-6% -$7.05K 0.02% 671
2022
Q4 		$102K Sell
12,501
-405
-3% -$3.49K 0.01% 685
2022
Q3 		$74.9K Buy
+12,906
New +$74K 0.01% 698

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

Freedom Investment Management's PACB Position: Q3 2025 in Review

Freedom Investment Management sold out of Pacific Biosciences (PACB) in Q3 2025, closing a stake of 29,166 shares — an estimated $36.2K sold.

Freedom Investment Management first reported a position in PACB in Q3 2022 and held it in 12 quarters. The position peaked at $187K in Q2 2023. 208 funds tracked by Wall St. Rank hold PACB as of Q3 2025.

  • Freedom Investment Management reported no remaining Pacific Biosciences position as of Q3 2025 after selling out during the quarter.
  • Freedom Investment Management sold 29,166 Pacific Biosciences shares in Q3 2025, an estimated $36.2K.
  • Freedom Investment Management first reported a position in Pacific Biosciences in Q3 2022 and held it in 12 quarters.
  • Freedom Investment Management's Pacific Biosciences position peaked at $187K in Q2 2023.
  • 208 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2025.

Based on Freedom Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.